Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck KGaA Pill Cuts MS Relapse Risk in Half, With Side Effects
Merck KGaA Pill Cuts MS Relapse Risk in Half, With Side Effects
Merck KGaA Pill Cuts MS Relapse Risk in Half, With Side Effects
Submitted by
admin
on April 30, 2009 - 7:24am
Source:
Bloomberg
News Tags:
Merck KGaA
multiple sclerosis
MS
cladribine
Headline:
Merck KGaA Pill Cuts MS Relapse Risk in Half, With Side Effects
Do Not Allow Advertisers to Use My Personal information
